Search results
Showing: 7 of 17
Guide to the underlying data
Presentation of the data
As part of our commitment to open data, the NHSBSA publishes the underlying data of the Innovation Scorecard publication in a series of comma-separated variable (csv) files.
The data has been released in csv files as these…
Prescription Cost Analysis – England – 2022-23
Correction notice - SNOMED codes in the national summary tables were incorrectly formatted.
Read our correction notices page for more details.
Published 8 June 2023
This page was last reviewed and updated 27 July 2023.
Summary
Prescription…
Hormone Replacement Therapy - England - April 2015 to June 2023
Published 26 October 2023
Summary
This publication aims to describe the prescribing of hormone replacement therapy (HRT) medications in a primary care setting in England that are dispensed in the community. This does not include data on medicines…
Prescription Cost Analysis – England – 2021/22
Published 9 June 2022.
Summary
Prescription Cost Analysis (PCA) provides details of the costs and volumes of all prescriptions dispensed in the community in England.
We consulted on the content and methodology used in this publication during…
Prescription Cost Analysis – England 2020-21
Published 10 June 2021.
Summary
Prescription Cost Analysis (PCA) provides details of the number of items and the Net Ingredient Cost (NIC) of all prescriptions dispensed in the community in England.
We consulted on the content and methodology…
Guidance and glossary
Background
Innovation scorecard overview
The Innovation Scorecard is an action taken from the Department of Health and Social Care's (DHSC) paper titled "Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS" (IHW)…
Estimates Report
Key findings
The comparison of expected uptake to the actual volume of medicines used in the NHS in England is available in the national level medicine groupings interactive dashboard.
You can find the dashboard on the online web platform.
The…